IP Library › Granted Patent US 6,987,163
Granted Patent B2
US 6,987,163 · App. 10/213,694 · Granted Jan 17, 2006

Modified polybenzimidazole (PBI) membranes for enhanced polymer electrochemical cells

Assignee: Research Foundation of the State University of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,987,163
App. No.
10/213,694
Granted
Jan 17, 2006
Kind
B2
Abstract

The invention relates to a modified polybenzimidazole (PBI), membranes that are fabricated from these polymers, and their use in electrochemical applications. These membranes have high ionic conductivity and are suitable for solid polymer electrolytes in electrochemical applications, especially for high temperature polymer electrolyte membrane (PEM) fuel cells.

Claims (12)

1. A modified polybenzimidazole having a chemical structure characterized by the following recurring unit:

wherein X is selected from the group consisting of: H,CH 2 CH 2 CH 2 SO 3 H, PO(OCH 2 CH 3 ) 2 , PO(OH) 2 , and PO(OCH 3 ) 2 ; and R is selected from the group consisting of: Br, PO(OCH 2 CH 3 ) 2 , PO(OH) 2 , and PO(OCH 3 ) 2 ; and having a number average molecular weight between 2,000 and 1,000,000 Da.

2. The modified polybenzimidazole of claim 1 , wherein at least some of the X and R groups contain PO(OCH 2 CH 3 ) 2 and PO(OCH 3 ) 2 .

3. The modified polybenzimidazole of claim 2 , wherein said X and R groups have a degree of substitution ranging from 0.3 to 3.5.

4. The modified polybenzimidazole of claim 1 , wherein said X and R groups are PO(OCH 2 CH 3 ) 2 and PO(OCH 3 ) 2 and have a degree of substitution ranging from 0.3 to 1.0, and said modified PBI is soluble in both polar aprotic solvents selected from the group consisting of: N,N-dimethyl formamide; N,N-dimethyl acetamide; dimethyl sulfoxide; and in acids selected from the group consisting of trifluoroacetic acid, concentrated sulfuric acid, and phosphoric acid.

5. The modified polybenzimidazole of claim 1 , wherein X and R groups are PO(OCH 2 CH 3 ) 2 and PO(OCH 3 ) 2 and have a degree of substitution ranging from 2.0 to 3.5, and said modified PBI is soluble in lower alcohols selected from the group consisting of: methanol, ethanol, isopropanol, and in polar aprotic solvents selected from the group consisting of N,N-dimethyl formamide, N,N-dimethyl acetamide, and dimethyl sulfoxide.

6. The modified polybenzimidazole of claim 1 , wherein at least one or more of the X groups is CH 2 CH 2 CH 2 SO 3 H.

7. The modified polybenzimidazole of claim 2 , wherein a further modification is hydrolysis.

8. The modified polybenzimidazole of claim 7 , wherein the further modification is carried out by a trimethylsilyl halide selected from the group consisting of: trimethylsilyl bromide, trimethylsilyl chloride, trimethylsilyl iodide, and trimethylsilyl chloride and iodide.

9. The modified PBI of claim 4 , wherein bromine-treated trifluoroacetic acid dissolves the modified PBI.

10. The modified polybenzimidazole of claim 5 , wherein the hydrolyzed modified polybenzimidazole contains both sulfonic and phosphonic acid groups.

11. The modified polybenzimidazole of claim 8 , wherein said iodide of the trimethylsilyl chloride and iodide, is selected from the group consisting of: potassium iodide, sodium iodide, and lithium iodide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2002
From: CABASSO, ISRAEL; YUAN, YOUXIN; JOHNSON, FREDERICK E.
To: THE RESEARCH FOUNDATION OF THE STATE OF NEW YORK
Reel/Frame 013182/0092 →
Continuity (1)
Related Publication 20040028976A1 · Feb 12, 2004